Hackensack Meridian Health to Pilot Combined Watson for Oncology and Cota Technology to Power Value-Based Clinical Decision Support in Cancer Care
IBM Watson Health, Cota, and Hackensack Meridian Health, an integrated healthcare system in New Jersey, today announced a collaboration to pilot a combination of IBM Watson and Cota technology for the first time. The goal is to bring Cota’s value-based care and real-world data into IBM’s Watson for Oncology clinical decision support tool, which Hackensack Meridian Health oncologists will then use in a pilot to help inform patient care. The goal is ultimately to help oncologists make evidence- and outcomes-based clinical decisions for their cancer patients, which could reduce total cost of care.
via IBM Press Releases – All Topics – United States https://ibm.co/2cyz2Mh
June 2, 2017 at 04:03AM